The real cost of BRCA testing: why you shouldn’t let the price tag block your care

Navigating the BRCA cost landscape

BRCA testing costs have shifted significantly, and understanding how the pricing landscape has changed could shape the decisions you make about your care.

When Angelina Jolie shared her story in 2013, she also shared something that stopped a lot of people in their tracks, Angelina Jolie’s BRCA testing reportedly cost several thousand dollars when she underwent it in 2013, though actual costs can vary widely depending on your location and insurance coverage. For many, that number felt insurmountable. The fear of that price tag has lingered ever since, quietly discouraging people from pursuing information that could be genuinely life-saving.

But that number belongs to a different era. That same year, the Supreme Court ruled that human genes cannot be patented, a landmark decision that broke the monopoly one company held over BRCA testing. As competition entered the market, costs began falling. What once required a multi-thousand-dollar investment became far more accessible.

Today, the range varies depending on your testing provider and billing situation. BRCA testing typically costs around $1,500 on average when submitted to insurance, though costs may vary. At-home or direct-to-consumer BRCA testing options are available, though they may have significant limitations in accuracy and comprehensiveness compared to clinical genetic testing. Understanding your specific options before assuming the worst will help you make an informed choice.

And here’s the point worth holding onto. Cost should no longer stand between you and a personalized care plan built on real genetic information. The next section breaks down exactly when insurance steps in, and how it’s possible to pay nothing at all.

When insurance pays: the $0 preventive pathway

For many high-risk individuals, BRCA testing is covered by insurance, and under the right circumstances, both the test and the counseling can cost you nothing at all.

The foundation of this coverage sits with the U.S. Preventive Services Task Force (USPSTF), which issued a Grade B recommendation for BRCA-related risk assessment in women who have a personal or family history suggesting an increased risk of hereditary breast or ovarian cancer mutations. Under the Affordable Care Act, any preventive service carrying a Grade B recommendation or higher must be covered by most private insurance plans without cost-sharing. That means no copay, no deductible, and no coinsurance for qualifying individuals.

Qualifying criteria tend to center on family history. You’ll typically meet the “high-risk” threshold if your history includes one or more of the following:

• A first-degree relative (parent, sibling, or child) diagnosed with breast cancer before age 50
• A family member with a known BRCA1 or BRCA2 variant
• Multiple relatives on the same side of the family with breast, ovarian, fallopian tube, or peritoneal cancer
• A male relative diagnosed with breast cancer
• Ashkenazi Jewish ancestry combined with any family history of these cancers

Counseling is covered too. The cost-sharing protection extends beyond the lab test itself to include genetic counseling sessions before and after testing. The counseling appointment is where a provider helps you interpret your results and understand what they mean for your care.

One important distinction to keep in mind: BRCA testing can be recommended for people at higher risk due to family history or personal risk factors, even before a cancer diagnosis is made. If you’ve been diagnosed with cancer, genetic testing can help doctors understand whether your cancer is caused by an inherited mutation, which may affect your treatment options. This distinction shapes how Medicare and Medicaid approach BRCA coverage, which we’ll break down in the next section.

Medicare and Medicaid coverage for those diagnosed

Medicare and Medicaid follow different rules for BRCA testing, and coverage may be limited if you’re a healthy family member hoping to screen proactively.

Medicare’s diagnostic focus. Medicare doesn’t cover proactive BRCA screening for individuals who haven’t received a cancer diagnosis. If you fall into that category and your private insurer won’t step in either, you could be looking at the full BRCA testing cost without insurance, which depending on the lab can range from a few hundred dollars to several thousand. That gap is real, and it’s worth knowing about before you assume coverage exists.

Medicaid’s state-by-state variability. Medicaid operates with coverage policies set at the state level for BRCA testing. Insurance coverage criteria for BRCA testing vary between private insurers, Medicare, and Medicaid plans, and may depend on factors such as your state of residence and whether your plan requires pre-authorization. Some states are more expansive, others are quite narrow. Checking your state’s specific Medicaid policy, or asking your care team to advocate on your behalf, is a practical first step before assuming you’re covered or uncovered.

For those who don’t meet Medicare or Medicaid criteria, out-of-pocket options have expanded significantly in recent years, and the pricing landscape may be more accessible than you’d expect.

Paying out-of-pocket for affordable lab tests

If insurance denies your claim or you simply don’t meet the coverage criteria, direct-to-consumer labs have made out-of-pocket BRCA testing significantly more affordable.

Direct-to-consumer labs have driven prices down to a range that, while still meaningful, is no longer the barrier it once was. Some direct-to-consumer labs may offer BRCA testing options in the $250–$500 range, though pricing can vary and it’s worth checking current costs and coverage with your provider or the lab directly. Choosing the right lab before your blood is drawn can save you thousands.

The hidden cost most people miss is genetic counseling. This fee is almost always billed separately from the lab itself. Whether you go direct-to-consumer or through a clinic, you’ll likely owe both. Counseling helps you understand what a positive or negative result actually means for your personalized care plan and your family members.

Physician-initiated online orders offer another path worth knowing about. Some platforms allow a physician to order BRCA testing on your behalf digitally, bypassing the traditional referral chain and the markups that come with it. This approach is particularly relevant if you’re pursuing BRCA testing for clinical trial eligibility, where speed and cost both matter. It won’t eliminate the counseling fee, but it can meaningfully reduce the lab portion.

Even at $250 to $500, cost remains a real obstacle for many patients. The good news is that financial assistance programs, from lab manufacturers and nonprofit organizations alike, can reduce that number further still.

Financial assistance and manufacturer programs

BRCA testing financial assistance programs can bring your out-of-pocket cost down to as little as $0, and many patients who assume they can’t afford testing actually qualify.

Many genetic testing labs offer financial assistance programs that can help reduce BRCA testing costs for eligible patients, including flexible payment options. These programs aren’t widely advertised, which means you often have to ask directly. But they exist precisely for situations where cost is the only barrier standing between you and a potentially life-saving result.

Income thresholds vary by program, but many BRCA testing programs offer financial assistance based on household income, and you may qualify for deeper discounts if your income falls in a lower range. It’s worth asking your healthcare provider or the testing laboratory about what assistance programs you might be eligible for. To give you a rough sense of what that means in practice:

• Below 200% FPL, Many patients with household income below 200% of the Federal Poverty Level may be eligible for BRCA testing assistance programs that could reduce or eliminate out-of-pocket costs.
• 200–300% FPL, Many patients with household income in the 200–300% of the Federal Poverty Level range may be able to access BRCA testing for $50–$100 or less through available financial assistance programs.
• 300–400% FPL, Patients with household income in the 300–400% of the Federal Poverty Level range may qualify for partial assistance programs that can help reduce out-of-pocket costs for BRCA testing. It’s worth asking your care team or genetic counselor about assistance options available to you.
• Above 400% FPL, Standard pricing applies, though payment plans may be available

Non-profit resources can also ease the process. Organizations like FORCE (Facing Our Risk of Cancer Empowered) help patients navigate these applications, understand their eligibility, and connect with labs that offer the best terms for their situation. And it’s worth knowing that you don’t have to figure this out alone.

One practical step. Ask your care team for a financial hardship form before your blood draw. Many labs accept these forms as part of the assistance application, and submitting one early can prevent a surprise bill from arriving weeks later. When you’re ready to look at the full picture, including what self-pay testing costs today and how all of these options stack up, the next section breaks it all down clearly.

What you need to know about BRCA costs

BRCA testing costs have dropped significantly, financial assistance is widely available, and insurance coverage rules are more patient-friendly than most people assume, but only if you know where to look.

The numbers worth keeping in mind break down clearly:

• Self-pay pricing: Direct-to-consumer genetic tests are available for a few hundred dollars.
• ACA-qualifying patients: The ACA requires many insurance plans to cover certain preventive health services with no copay or deductible, and BRCA testing may be covered under this requirement if your doctor orders it as a preventive measure, so it’s worth checking with your insurance company about your specific coverage.
• BRCA testing Medicare coverage: Medicare typically requires an active cancer diagnosis before it will pay, and proactive screening for healthy individuals is rarely covered, so it’s worth confirming your eligibility with your care team before ordering a test.
• Genetic counseling: This service commonly adds $150–$500 on top of a BRCA lab fee, so budget for it unless your testing package explicitly bundles it in.
• Financial assistance programs: These can close the gap for patients earning up to 400% of the federal poverty level, as covered in the previous section.

Understanding where you stand across insurance type, income level, and risk criteria is the first step toward getting tested without unnecessary delay. What comes next matters just as much. Your results can open doors to treatments and care pathways built around your specific genetic profile.

Using your BRCA test results for targeted treatment

Affordable BRCA testing helps you access a personalized care plan that can connect you to treatments most patients never knew were available to them.

Your BRCA status is one of the most important filters your care team uses when evaluating targeted therapies. PARP inhibitors are a class of drugs specifically designed to exploit the DNA repair defects caused by BRCA mutations, and eligibility for many of those clinical trials begins with a confirmed genetic result. Without that data, your care team is working with an incomplete picture. With it, they can match you to therapies that are built around your biology.

Think of the test as an investment, not an expense. The cost-effectiveness of BRCA 1/2 genetic testing has been well-documented in clinical literature, particularly when results lead to preventive interventions or targeted treatment pathways. That upstream knowledge can shape every decision that follows, from surgery options to systemic therapy to clinical trial eligibility.

You’ve already taken an important step by asking the right questions about cost and access. Now let your results do the work by connecting your BRCA status to NCCN-aligned treatments and clinical trials designed for your specific profile.

Disclaimer: The information provided in this article is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Outcomes4Me is not acting as your caregiver, and any suggestions or guidance offered should not replace the advice of your healthcare provider or qualified medical professional. Always seek the guidance of your physician or other qualified health provider with any questions you may have regarding a medical condition.